Metabolic syndrome predicts poor outcome in patients with systolic heart failure who received implantable-cardioverter defibrillator for primary prevention of sudden cardiac death [presentation] Presentation uri icon
  • Ahmed, I.   Presenter  
  • Dahiya, R.   Presenter  
  • House, Chad M., BS, RDCS, FASE   Presenter  
  • Nelson, William B., MD   Presenter  
  • Zhu, Dennis W., MD   Presenter  
  • Research
  • Heart Diseases
  • Metabolic Syndrome
  • Mortality
  • Prevention
  • Retrospective Studies
  • Surgery